Adverse drug events (ADEs) are untoward medical events temporally associated with the use of drug products, regardless of etiology. Their monitoring and reporting is essential to ensure that drug product’s favourable benefit–risk profile is maintained throughout its lifecycle. Product safety is a top priority for Elan Pharma (India) Pvt. Ltd. and its manufacturing partners (from now on referred to as “Elan”). To achieve this imperative, we are committed to conducting post-marketing safety surveillance of all Elan’s drug products. If you would like to report an adverse event associated with the use of our products, please email us at the contact email address listed below.

Note: Any person who misuses the below listed email address by reporting content unrelated to adverse events associated with use of Elan’s products shall be subject to appropriate corrective action, up to and including legal action. All personal information included while reporting adverse drug events related to Elan’s products will be sent to the product management team and may be shared with regulatory authorities, as needed. Submission of an adverse event report
does not mean that the adverse event can be attributed to a healthcare provider or Elan’s product. By using the below listed email address, you accept and agree to the above information. Contact Email: drugsafety@elanpharma.in